Episode 4 – Rishad Tobaccowala

R.J. Lewis and Rishad Tobaccowala have packed a lot into this 30 minute conversation which covers the “3rd Connected Age” of Data-to-Data connections through AI...

In PBMs’ Search for Survival, Transparency is the Answer

Within the last couple months, President Trump reiterated his intention to end the opioid crisis, notably adding, “we are holding big Pharma accountable.” Drug manufacturers and...

Episode 5 – Dave Chase

With drug prices steadily rising and the opioid crisis in full swing with no end in sight, it's no secret that America's healthcare system is broken, in crisis, and its lawmakers...

An Update on Digital Health – Compliance Considerations

Artificial Intelligence (AI) holds the potential to change the health care experience for patients by providing new tools that modify the way patient engagement occurs and creating platforms that...

Guest Episode – Darshan Talks – Is legal really necessary on your promotional review...

The Pharma Marketing Podcast is pleased to present this special guest episode from our friend and Editorial Advisory Board member Darshan Kulkarni, Insys & Mallinkrodt: Is legal really necessary on your promotional...

April 19th is World IBS Day

The IBS Patient Support Group, an online patient community for Irritable Bowel Syndrome sufferers founded by Jeffrey Roberts, announced today a new initiative to designate April 19th as World...

Learnings from ExL Events and Paul Ivan’s Inaugural Digital Health for Pharma (DH4P) Conference

Digital health is growing exponentially. Its potential for positively impacting health outcomes is mind boggling. Yet, multiple obstacles continue to stand in the way of its success – from...

Real-Time Analytics: The Future of Commercial Effectiveness

Effective marketing and sales in the pharmaceutical space requires the utilization of emerging technologies to analyze current market landscape and customer behavior. This shifting mindset towards the significance of analytics to devise...

The Top 3 Reasons Brands Are Turning to Regional Marketing in 2019

"In 2001, Pfizer started doing Regional Marketing to squeeze extra share/volume out of the Lipitor Brand (and a few other $1B blockbusters). I remember, when I was on...

Cross-Functional Collaboration Drives Launch Success

The launch of a new therapeutic product is as exciting as it is challenging. The need to navigate the ever-growing complexity of the health care landscape, the evolution of...
- Advertisement -